Company: TYRA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000950170-25-066942
Chunk: 1

Company: Tyra Biosciences, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 1
---
 at March 31, 2025 and    December 31, 2024, respectively, and 53,089,957 and    50,749,945 shares outstanding at March 31, 2025 and    December 31, 2024, respectively.

     5

     5

     Additional paid-in capital

     602,299

     593,687

     Accumulated other comprehensive income

     688

     770

     Accumulated deficit

     (279,458
     )

     (251,311
     )

     Total stockholders’ equity

     323,534

     343,151

     Total liabilities and stockholders’ equity
      
     $
     343,476

     $
     363,558

See accompanying notes to unaudited condensed financial statements.